
Eyecelerator @ AAO 2023
San Francisco Marriott Marquis | Thursday, November 2
CONFERENCE SPEAKERS
*Panels are in development and speakers are subject to change.

EyeBio
Anthony P. Adamis, MD
Chief Scientific Officer

Alcon
Sebastien Allard
VP, Corporate Development Strategy

Ora
David Bingaman
Chief Development Officer

Genentech
Christoper Brittain, MBBS
Head of Global Development

Janssen
Victor Chong, MD
Global Head of Retina

Lineage Cell Therapeutics, Inc.
Brian Culley, MS
CEO

ONL Therapeutics, Inc.
David Esposito
Chief Executive Officer

Advanced Vision Care
Nicole Fram, MD
Managing Practice Partner

Moorfields Eye Hospital
Gus Gazzard, MD
Director

Raymond James
Andrew Gitkin
Vice Chairman, Health Care Investment Banking

LifeLong Vision
Ranya G. Habash, MD
CEO

Bausch + Lomb
Chuck Hess
Global VP

Wills Eye Hospital
Allen C. Ho, MD
Director of Retina Research
.jpg)
Eyenovia
Sean Ianchulev
Chairman and Founder

Aurion Biotech
Eris Jordan, OD
VP Global Clinical and Medical Affairs

InterWest Partners
Gil Kliman, MD
Managing Partner

Janus Henderson Investors
Daniel Lyons, PhD
CFA

Shifamed
Mariam Maghribi
Chief Business Officer

American Academy of Ophthalmology
Stephen D. McLeod, MD
CEO

PharmaLogic Development
Gary D. Novack, PhD
President

REGENXBIO
Steve Pakola, MD
Chief Medical Officer

All Eyes Consulting
Namrata Saroj, OD
Principal

Zeiss
Steven C. Schallhorn, MD
Chief Medical Officer

Eyenuk
Kaushal Solanki
CEO and Founder

Vance Thompson Vision
Vance M. Thompson, MD
Founder

Allergan, an AbbVie Company
Ramin Valian
VP, US Eyecare

Retina Consultants of Texas
Charles Wykoff, MD, PhD
Surgical Retinal Specialist

Baylor School of Medicine
Zaina Al-Mohtaseb, MD
Director of Research

California Retina Consultants
Robert L. Avery, MD
Founder/CEO

Retina Vitreous Associates
David S. Boyer, MD
Sr. Partner

Food and Drug Administration
Wiley A. Chambers, MD
Director, Division of Ophthalmology

Visionary Ventures
Lori-Ann Christie, PhD
Principal

Eyepoint Pharmaceuticals
Jay S. Duker, MD
CEO

Food and Drug Administration
Malvina B. Eydelman, MD
Director, Ophthalmic Technology

Apellis
Cedric Francois, MD
CEO

Aviceda Therapeutics, Inc.
Mohamed A. Genead, MD
Co-Founder, CEO & President

Iveric Bio
Adrienne L. Graves, PhD
Former Board Chair

Iveric Bio
Erin Henry
VP, Strategy & Innovation

Alcon
Kendra Hileman
Head of Instrumentation R&D

Canaan Partners
Wende Hutton
General Partner

Market Scope
Kristen Harmon Ingenito
Director of Ophthalmics

Stanford Human Perception Lab
Khizer R. Khaderi, MD, MPH
Director

Minnesota Eye Consultants
Richard Lindstrom, MD
Founder and Attending Surgeon

Perceive
Angela Macfarlane
CEO

Neurotech
James V. Mazzo
Executive Chairman

Vivek Natarajan
AI Researcher

Notal Vision
Kester Nahen, PhD
CEO

Cleveland Clinic
Aleksandra V. Rachitskaya, MD
Associate Professor, Cole Eye Institute

UCSF School of Medicine
Julie Schallhorn, MD, MS
Associate Professor

Washington University in St. Louis
Arsham Sheybani, MD
Associate Professor

Neurotech
Richard Small
CEO

Duke University
Lejla Vajzovic, MD
Director, Surgical Vitreoretinal Fellowship

Regeneron
Robert Vitti, MD
Vice President